Showing results (971-980 of 1,163) with videos related to

Sort By:
Pageof 117
Circulation. Heart Failure|June 23, 2023
Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial FibrillationToru Kondo, Karola S Jering, Pardeep S Jhund, et al.
European Heart Journal|April 13, 2021
A call to action for new global approaches to cardiovascular disease drug solutionsGemma A Figtree, Keith Broadfoot, Barbara Casadei, et al.
Circulation|April 20, 2021
A Call to Action for New Global Approaches to Cardiovascular Disease Drug SolutionsGemma A Figtree, Keith Broadfoot, Barbara Casadei, et al.
JACC. Heart Failure|April 4, 2020
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection FractionJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
European Journal of Heart Failure|February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trialClara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
European Journal of Heart Failure|May 3, 2024
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fractionMingming Yang, Toru Kondo, Atefeh Talebi, et al.
Circulation. Heart Failure|October 27, 2023
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVERToru Kondo, Jawad H Butt, James P Curtain, et al.
JAMA Cardiology|March 28, 2026
Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical TrialHenri Lu, Annamaria Kosztin, Brian L Claggett, et al.
American Heart Journal|May 17, 2026
Cardiovascular Regulatory Science: Accelerating the Path from Bench to BedsideSerge Korjian, C Michael Gibson, Jonathan Seltzer, et al.
European Journal of Heart Failure|October 30, 2024
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trialYogesh N V Reddy, Javed Butler, Kevin J Anstrom, et al.
Pageof 117